# Tina Boville

> Tina Boville is the co-founder and CEO of Aralez Bio, a Berkeley-based biotechnology company using directed evolution to make noncanonical amino acids - the building blocks behind a growing share of modern medicines. A biochemist trained at the University of Colorado and Caltech, where she worked in Nobel laureate Frances Arnold's lab, Boville turned an engineered enzyme platform into a company that can produce over 100 amino acids in single-step reactions, cutting manufacturing waste by up to 99%. She has been named to MIT Technology Review's Innovators Under 35, is an Activate Fellow, and in 2024 raised a $12 million Series A to scale production to tons per year.

- **Role:** Co-founder & CEO at Aralez Bio
- **Organizations:** Aralez Bio, Caltech, University of Colorado Boulder, Cyclotron Road / Activate, Amgen
- **From:** United States
- **Nationality:** American
- **Education:** B.A., Molecular, Cellular and Developmental Biology (MCDB), University of Colorado Boulder, Ph.D., Biochemistry, University of Colorado Boulder, Postdoctoral research, Resnick Prize Sustainability Fellow (Frances Arnold lab), California Institute of Technology (Caltech)
- **Known for:** Co-founded Aralez Bio (2019) with David Romney and Nobel laureate Frances Arnold, Named to MIT Technology Review's Innovators Under 35 (2020), Activate (Cyclotron Road) Fellow

## Career timeline

- **—** — Undergraduate in MCDB at CU Boulder; interned at Amgen's Boulder facility
- **—** — PhD in Biochemistry at CU Boulder; led the Graduate Teacher Program and worked with CU Green Labs on sustainability
- **—** — Resnick Prize Postdoctoral Fellow at Caltech in Frances Arnold's lab, co-developing the enzyme platform behind Aralez Bio
- **2018** — Her postdoc advisor Frances Arnold wins the Nobel Prize in Chemistry for directed evolution of enzymes
- **2019** — Co-founds Aralez Bio with David Romney and Frances Arnold
- **2020** — Named to MIT Technology Review's Innovators Under 35
- **2024** — Closes an oversubscribed $12M Series A led by Spero Ventures and Paladin Capital Group
- **2025** — Aralez Bio moves to a Berkeley facility capable of ton-scale production

## Achievements

- Co-founded Aralez Bio (2019) with David Romney and Nobel laureate Frances Arnold
- Named to MIT Technology Review's Innovators Under 35 (2020)
- Activate (Cyclotron Road) Fellow
- Recognized as a 'Biotech Founder to Watch'
- Built an enzyme platform producing 100+ enantiopure noncanonical amino acids in single-step reactions
- Reduced pharmaceutical manufacturing timelines from months to days and cut waste by up to 99%
- Won prizes from the Rothenberg Innovation Initiative and the Caltech Rocket Fund
- Raised a $12M Series A (2024) and secured a federal Defense Production Act award (with National Resilience) to build domestic ncAA supply chains
- Counts top 10 pharmaceutical companies among Aralez Bio's customers

## Latest updates

- **2024-10** — Closed an oversubscribed $12M Series A led by Spero Ventures with Paladin Capital Group and others.
- **2025-03** — Featured as a speaker at IOPC 2025.
- **2025-01** — Aralez Bio scaling into a Berkeley facility capable of ton-scale production of noncanonical amino acids.

## Links

- Website: https://aralezbio.com
- LinkedIn: https://www.linkedin.com/in/christinaes/
- Twitter/X: https://x.com/tinaboville

---

Profile page: https://yespress.io/tina-boville
Published by YesPress — https://yespress.io
Last updated: 2026-07-24